Skip to product information
1 of 1

OX40/TNFRSF4/CD134 Fc Chimera Protein, Rat

OX40/TNFRSF4/CD134 Fc Chimera Protein, Rat

Catalog Number: UA010929 Reactivity: Rat Conjugation: Unconjugated Brand: UA BIOSCIENCE
Price:
Regular price $256.00 USD
Regular price Sale price $256.00 USD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Species Rat
Synonyms Txgp1; OX40L receptor; ACT35
Accession P15725
Amino Acid Sequence

Val20-Pro210 with Human IgG1 Fc at C-Terminus

Expression System HEK293
Molecular Weight 60-80kDa (Reducing)
Purity > 95% by SDS-PAGE
Endotoxin <0.1EU/μg
Conjugation Unconjugated
Tag Human IgG1 Fc
Physical Appearance Lyophilized Powder
Storage Buffer PBS, PH7.4, 5% trehalose
Reconstitution Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
Stability & Storage

· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. 
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.  
· Please avoid repeated freeze-thaw cycles.

Reference

1. Cancer Res. Roles of OX40 in the pathogenesis and the control of diseases.Int J Hematol . 2006 Jan;83(1):17-22. Toshiyuki Hori.

Background

OX40, a member of the tumor necrosis factor receptor superfamily, is selectively expressed on activated T-cells. The engagement of OX40 during interactions between T-cells and dendritic cells is essential for the clonal expansion of antigen-specific T-cells and the establishment of T-cell memory. Recent animal model studies have highlighted the significant role of OX40 in the development of immunologic abnormalities, including inflammatory, autoimmune, infectious, allergic, and allotransplantation-related diseases. Inhibition of the OX40-OX40L interaction has demonstrated potential in preventing, curing, or alleviating these conditions. Conversely, OX40 activation can disrupt tolerance in cancer, reactivating antitumor immunity. These insights underscore the OX40/OX40L system as a promising target for immunotherapeutic interventions in the treatment of these diseases.

Picture

SDS-PAGE

1μg (R: reducing condition).

ELISA

Immobilized OX40 Ligand/TNFSF4 His Tag Protein, Mouse (Cat. No. UA011097) at 2.0μg/mL (100μL/well) can bind OX40/TNFRSF4/CD134 Fc Chimera Protein, Rat (Cat. No. UA010929) with EC50 of 3.98-4.88 ng/mL.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)